P

Poseida Therapeutics
D

PSTX

9.34000
USD
-0.04
(-0.43%)
Market Closed
Volume
68,091
EPS
-1
Div Yield
-
P/E
-15
Market Cap
910,323,324
News

Title: Poseida Therapeutics

Sector: Healthcare
Industry: Biotechnology
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline ofautologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.